{"status": "Ok", "redirect_url": "https://www.prnewswire.com//news-releases/immunitybio-inc-ibrx-facing-securities-class-action-amid-fda-warning-regarding-unsupported-cancer-treatment-claims-2-billion-market-capitalization-wiped-out----hagens-berman-302738761.html", "message": "News view counter 656910 successfully enlarged"}